Unicycive Therapeutics, Inc. (UNCY)

NASDAQ: UNCY · Real-Time Price · USD

6.73

+0.15 (2.28%)

Dec 9, 2025, 10:33 AM EST - Market open

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Novel Therapies	675.00K	Log In
Novel Therapies Growth	-29.02%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	675.00K	Log In
United States Growth	-29.02%	Log In